The Drug Pricing Database Tool Germany in a nutshell
The DRUG Pricing Database contains all the information required for ordering, dispensing and invoicing medicines and other articles in the usual pharmacy range. In addition to price information, it contains pharmaceutical-legal information and a large number of other packaging-related data. No other database illustrates the daily balancing act between the healing profession and the merchant as clearly as the Drug Pricing Database. It is the heart of modern merchandise management systems used in pharmacies and clinics. In addition, health insurance companies, institutions, authorities or pharmaceutical entrepreneurs profit from the Drug Pricing Database, which is indispensable for a safe fulfilment of legally anchored tasks and which takes into account the constantly rising need for information by continuous advancement. The data are based on reports from the providers to IFA GmbH. These are edited by ABDATA Pharma-Daten-Service and extended by essential additional information. The structured and careful collection of the data guarantees the reliability of the information.
The Drug Pricing Tool Germany – ABDA-Artikelstamm (Taxe) includes all economic data for all drugs sold in pharmacies in Germany.
- Determine initial pricing and launching sequence
- Secure maximum reimbursement
- Track competitor prices
- Improve market access and time-to-market strategies
- Assess business impact of major price changes and regulatory shifts
- Track the impact of patent expirations
- Optimize launch sequencing strategies
- Price comparison and price history back until November 2003
- The Drug Pricing Germany is updated twice a month
Pharma Industry, Pharma Trade, Health Insurance, Regulatory
Source: ABDATA PHARMA-DATA-SERVICE
This database can be accessed after purchasing the subscription package ‘Drug Pricing’ or ‘Premium’
What customers say
I am working with pharmazie.com everyday, especially with the Drug Pricing Tool Germany. Dapou Pharma is a Pharma-wholesaler & Parallel Trader and needs to have access to secure and up-to-date drug prices. The best in pharmazie.com is always to know which product is marketed in which country. Also the contact details of the pharmaceutical producers and marketing authorisation holders are most helpful.Salman Lolagar
CHECK OUT THIS DATABASE IN 5 STEPS
Enter “Humira” in the Drug Pricing Germany Tool field free text search.
Result list for the search Humira in the Drug Pricing Germany Tool
Detail info for Humira from AbbVie
Legal information for Humira in the Drug Pricing Germany Tool
The most important abbreviations in the drug pricing tool Germany
The most important abbreviations in the database ABDA article master estimate:
- AP Pharmacy required
- BTM narcotic
- DRO drugs
- EK pharmacy purchase price
- IMP reimport
- KP clinic pack
- N1 Therapy-appropriate pack size N1
- N2 Therapy-appropriate pack size N2
- N3 Therapy-appropriate pack size N3
- NA non-pharmaceuticals
- NL negative list
- OR original preparation
- RP prescription
- VK Pharmacy Sales Price
A unique identifier: the Pharmazentralnummer (PZN)
The basic data in the DRUG Pricing Database (ABDA-Artikelstamm) primarily serve for an unmistakable identification of the article. In addition to the PZN, attributes such as article description, dosage form, package size including unit of measurement of the quantity, article type and ABDATA product group code provide detailed information about the article.
The article description distinguishes between short name (26 digits) and long name (50 digits). For ranges such as compression and support stockings, the long names provide detailed information on quality, colour and size. The article type is used for differentiation if the short name, dosage form, package size and supplier are identical. This is the only way to distinguish the so-called standard packaging of a finished drug from hospital packaging, pandemic articles or approved canned goods for patient-specific drug supply. Each article is assigned an alphanumerically structured ABDATA merchandise group code. There are A and B material group codes. The A merchandise category code primarily identifies drugs requiring pharmacy services. In the A area, the character string following the first character (A) corresponds to the WHO ATC code . The ABDATA commodity group code AN02BA01 (Tab. 1.) results accordingly for Aspirin® tablets.
Example of an A commodity group code
Other analgesics and antipyretics
Salicylic acid and derivatives
Everything that is right: The legal information
Article classification as well as the corresponding tax regulations can be found in the legal information in the DRUG Pricing Database. If articles are assigned to certain categories, the other can exclude them. For example, an article cannot be classified as both a drug and a medical device at the same time. Other indicators also apply: A veterinary drug is always also flagged as a drug. The following categories are distinguished:
- Drugs according to AMG
- veterinary medicines
- Medical device according to valid medical device law
- Drug/chemical (this includes substances which are used in pharmacies as starting material is used for the manufacture of medicinal products or other products and laboratory substances).
- Dietetic according to the regulation on dietetic food, including reference to § 31 SGB V 
- Food supplements according to NemV
- Food according to LFGB 
- Cosmetic according to Regulation (EC) No. 1223/2009
- authorised biocide or plant protection product
AMG: Arzneimittelgesetz (German Medicine Law)
Dietetic according to §31 (5) SGB V: Balanced diets for enteral nutrition reimbursable within the scope of drug supply
NemV: Nahrungsergänzungsmittelverordnung (Ordinance on Food Supplements)
LFGB: Lebensmittel- und Futtermittelgesetzbuch (Food and Feed Code)
Down to the last cent: price information
Price information is at the heart of the article information within the DRUG Pricing Database (ABDA-Artikelstamm) and its additional module ABDA-Artikelstamm Plus V. For prescription drugs, pricing is complex and strictly regulated. The AMPreisV according to AMG serves to calculate these prices and regulates fixed surcharges on the manufacturer’s selling price up to the final price, which is the same in all pharmacies. The fixed amounts, the reimbursement amounts according to § 130b SGB V or the discount contracts (in which the pharmaceutical entrepreneur promises an agreed discount to a health insurance company) have an influence on the pricing. If a drug is subject to the fixed amount regulation, the health insurance funds do not reimburse more than the maximum amount fixed for it. If the price of a drug is higher than the fixed amount, the patient must pay the surcharge himself. However, if the patient receives drugs that are 30 percent or more below the reference amount, he is exempted from the statutory co-payment. If a health insurance company agrees discounts for certain preparations with individual providers, it can exempt its members from the co-payment up to 50 percent or 100 percent.
All about Distribution: Sales and Reference Information
The references to the distribution channels reported by the supplier provide important information on the purchase of the articles. A distinction is made between distribution via public pharmacies, pharmaceutical wholesalers, hospital pharmacies or pharmacies supplying hospitals or other retail outlets. If an article is a clinic module, reference is made – if reported by the supplier – to the corresponding clinic packs of which this article is a component. A hospital module describes a finished drug package that is a subunit of a hospital package and may not be dispensed separately.
The supplier informs about the sales status whether his articles are “in sales”, “out of sales” or “withdrawn”. Articles that are marked as “not for distribution” may be sold off, provided there is nothing to the contrary (such as their marketability). A reference indicator (PZN) is used to refer to a successor product for articles that are “not for sale”. The referenced follow-up article is a sensible alternative with the same or similar intended purpose; suppliers of drugs or medical devices are required to interpret their notifications so narrowly that drug/product safety is guaranteed. Only drugs which are withdrawn from the market in connection with the negotiations on the reimbursement amount (in accordance with § 130b SGB V and are therefore no longer intended for sale and distribution) are given the “withdrawn” sales status. These articles will therefore be deleted from the database three months after their identification. However, this is an extremely rare case.
The link between original and imported preparations via a reference (PZN) as well as the import groups developed by ABDATA serve the implementation of the framework agreement according to § 129 SGB V. Corresponding comparisons, as provided for in the framework agreement, can thus be carried out on the basis of the currently reported prices (determination of the import quota).
An address database integrated in the Drug Pricing Database (ABDA-Artikelstamm) informs about the suppliers of the listed articles. It is based on the IFA data and is supplemented by the service lines created by ABDATA. The service lines provide information about further communication and information channels that facilitate direct contact (e.g. to the medical-scientific department).
Not above 8 °C: Packing and Storage Information
For the storage of the articles different data are essential. For example, it is necessary to know which storage temperatures must not be exceeded or undercut for certain articles. In the case of temperature-sensitive articles, the reference to transport within a cold chain must also not be neglected. Information as to whether articles should be stored in a dry place, whether there is a risk of breakage, whether they should be stored lying down or upright, or whether they should be protected from light or sunlight can be found in the Drug Pricing Database (ABDA-Artikelstamm) for specific packs. In addition, dimensional data are available which include the outer wrapping in the case of packaged articles. The packaging dimensions are required in particular when the picking of articles is automated. If an article has an expiry date, the guaranteed shelf life of the article is indicated in months, calculated from the time of manufacture. The shelf life refers to the unopened condition of the article.
These databases could also be interesting for you
The new Falsified Medicines Directive 2019 - which medicines are affected? As of 9. February 2019, the Falsified Medicines Directive (2011/62/EU), which was adopted in 2011, has officially come into force. What does this mean for the affected players such as...
Estimating the final price of a prescription-only product At a glance: Pricing for pharmaceuticals in Germany Supply and demand determine the price, at least considering most branches of a free market economy. This basic principle also applies to non-prescription...
Drug Pricing Tool German Medicinal Products - ABDA-Artikelstamm (Taxe)The Drug Pricing Tool German Medicinal Products - ABDA-Artikelstamm (Taxe) includes all economic data for all drugs sold in pharmacies in Germany. Pressed to make pricing decisions? Need to...